Skip to content

Tru Niagen vs Elysium Basis: Which NR Supplement Wins?

Compare Tru Niagen and Basis on current price, formula, supply and cancellation terms. Why neither biomarker percentages nor extra ingredients prove a winner.

By Marcus HaleLongevity Research Editor
Updated

4 min read · 16 sources

On this page

Tru Niagen is the simpler NR-only choice; Basis adds pterostilbene and has a different purchase commitment. Both have relevant human research, but neither is proven to slow aging, and comparisons between their NAD+ percentages do not establish clinical superiority.

The current prices also do not support a blanket “Basis costs twice as much” claim. For the small standard packs, Tru Niagen lists $49 one-time or $39.20 on its one-month subscription. Basis lists $65 one-time, $50 on its monthly subscription, or $480 prepaid for 12 months with monthly shipments 1015. The annual Basis plan works out to $40 per pouch; it is not a $40 month-to-month subscription.

Affiliate partner

MadeMed

NAD+ injection & nasal spray, in 23 states

See MadeMed

Compare the actual products

Tru Niagen 300 mg provides a one-capsule daily serving and 30 capsules in its standard small pack. It contains Niagen NR rather than the NR-plus-pterostilbene combination in Basis. The Tru Niagen review explains its ingredient research; its buying review covers the specific product offer.

Basis combines 250 mg NR with 50 mg pterostilbene per two-capsule serving. Its NR formulation is discussed in the Basis review; the studies call the combination NRPT. Choosing it adds another active compound, not merely a different capsule count. The NR versus NMN comparison covers a separate precursor choice.

Product comparison

Swipe table to compare all columns →

DetailTru Niagen 300 mgElysium Basis
Daily dose300 mg NR; 1 capsule250 mg NR + 50 mg pterostilbene; 2 capsules
One-time$49$65
Monthly$39.20$50
Longer planBulk 3/6 month scheduled chargesAnnual $480 upfront, monthly shipping
One-time and monthly prices refer to the standard small packs. Longer plans have different payment commitments. A milligram comparison does not establish clinical equivalence.

Price depends on commitment, not just brand

At the displayed one-month subscription rates, twelve payments would total $470.40 for Tru Niagen and $600 for Basis, before applicable taxes or other charges. Basis's annual option is $480 paid upfront, with monthly delivery. That makes the annual comparison much closer than the monthly comparison, while creating a larger initial commitment.

Tru Niagen also displays bulk recurring options: $101.60 for 90 capsules delivered every three months and $195.20 for 180 capsules every six months 15. These are the full scheduled charges, not monthly payments. Compare the same serving and supply duration, and confirm the final plan before purchase.

Cost per milligram can help explain a label but does not determine equivalent absorption, symptom benefit or safety. Nor should a cheaper bulk plan be chosen solely because a higher dose looks better on paper. Product-dose and clinical-outcome questions are separate.

Cancellation and returns differ

Tru Niagen advertises the ability to pause, skip or cancel subscriptions. Its return policy requires eligible products to remain factory-sealed and in original condition within 30 days; it does not promise a refund after trying an opened bottle 1516. The policy contains both customer-shipping-responsibility language and a portal-label provision, so confirm return instructions rather than assuming every return cost is covered.

Elysium's terms require a cancellation request at least 48 hours before renewal. Canceling in the middle of a prepaid period does not refund that period, and the remaining shipments continue 11. For a first purchase, that distinction may matter more than a small per-pouch saving. A cancellation stops a future commitment; it is not automatically a refund for the current one.

Testing claims need the right product and lot

NSF's directory lists Basis with specified lots,60 capsules and a two-capsule serving 12. That supports a defined quality claim, not a clinical benefit. Check the product and lot you actually receive rather than treating the company's badge as a blanket endorsement of every item.

Tru Niagen's product page describes third-party testing by Alkemist Labs and provides a route to individual test results 15. That is a different verification claim, not automatically the same certification program. A quality comparison should name the program and scope rather than assume one company's testing substitutes for another's.

Both raise NAD+, but the percentages are not a contest

Foundational NR studies show oral availability and higher NAD+ levels 12. The 2019 Niagen dose-ranging trial reported 22%,51% and 142% increases within two weeks at 100,300 and 1000 mg, respectively, maintained through the eight-week intervention 3. It does not mean the biggest percentage produces the best clinical outcome.

The 2017 NRPT trial is the source of Basis's approximately 40% standard-dose claim 4. These are separate studies with different participants and methods; a 51% versus 40% advertisement is not a head-to-head comparison. A small NRPT hospital safety study in acute kidney injury is also not evidence that either retail supplement prevents kidney disease 5.

At a glance

QuestionWhat to know
Blood NAD+Separate biomarker trials; no direct brand winner
PterostilbeneAdded active ingredient; superiority not established
Clinical benefitsPopulation- and outcome-specific; not proven anti-aging
ContractCompare total charge, supply and cancellation terms
Choose the formulation and commitment, not the largest biomarker percentage.

Does pterostilbene add a proven benefit?

A clinical advantage over NR alone has not been established by a convincing head-to-head trial. The 111-person NRPT fatty-liver study missed its primary liver-fat endpoint, despite some secondary marker improvements 13. The 2026 menopause report was a small uncontrolled pilot, so it cannot distinguish a treatment effect from other explanations or isolate pterostilbene's role 14. See the menopause review and NAD+/resveratrol discussion for context.

Results with NR alone also need restraint. Muscle and cognition findings have not consistently shown clinical improvement despite biomarker changes, and a muscle-function meta-analysis did not establish a reliable broad benefit 678. The NICE trial's walking-distance result was in peripheral artery disease, a specific population rather than a generic wellness outcome 9.

Which is the more practical choice?

Tru Niagen may suit someone who deliberately wants NR alone and a smaller initial subscription charge. Basis may suit someone who specifically wants NRPT, values the relevant NSF listing and accepts its terms. Neither choice establishes that a supplement is needed or that it will improve healthy aging.

Read the Basis review for the formulation tradeoff, the NAD+ supplement guide for the wider shelf and the NAD+ evidence guide before turning any price comparison into a treatment decision. The NAD+ provider index compares a separate set of service and product offers.

Frequently asked questions

Is Basis twice the price of Tru Niagen?

Not as a general current claim. Small-pack one-month subscriptions list $50 for Basis and $39.20 for Tru Niagen. Basis also has a $480 prepaid annual option; bulk Tru Niagen plans have their own scheduled charges. Compare equal supply and commitment.

Which raises NAD+ more?

Both have biomarker research, but percentages from different trials are not a head-to-head comparison and do not predict clinical benefit.

Does pterostilbene make Basis better?

A meaningful clinical advantage over NR alone has not been established. Combination trials cannot isolate pterostilbene without an appropriate comparator.

Can I try either product and return an opened pack?

Do not assume so. Elysium describes orders as final sale and does not refund the unused prepaid period. Tru Niagen requires eligible returns to be unopened and factory-sealed within 30 days. Check the current terms before purchase.

References

  1. Trammell SA, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/27721479/
  2. Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/29599478/
  3. Conze D, Brenner C, Kruger CL (2019). Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/31278280/
  4. Dellinger RW, Santos SR, Morris M, et al. (2017). Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study. npj Aging and Mechanisms of Disease. https://pubmed.ncbi.nlm.nih.gov/29184669/
  5. Simic P, Vela Parada XF, Parikh SM, et al. (2020). Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses (EpiNAD). BMC Nephrology. https://pubmed.ncbi.nlm.nih.gov/32791973/
  6. Elhassan YS, Lavery GG, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. https://pubmed.ncbi.nlm.nih.gov/31412242/
  7. Orr ME, Kotkowski E, Ramirez P, et al. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. https://pubmed.ncbi.nlm.nih.gov/37994989/
  8. Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/
  9. McDermott MM, Martens CR, Domanchuk KJ, et al. (2024). Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/38871717/
  10. Elysium Health (2026). Basis product and pricing. Elysium Health website.
  11. Elysium Health (2026). Refund policy and subscription terms. Elysium Health website.
  12. NSF (2026). Basis certification listing. NSF Certified for Sport. https://www.nsfsport.com/certified-products/listing-detail.php?id=1451522
  13. Dellinger RW, Holmes HE, et al. (2022). Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double-blind, placebo-controlled clinical trial. Hepatology. https://onlinelibrary.wiley.com/doi/full/10.1002/hep.32778
  14. Holmes HE, Srivastava K, et al. (2026). Nicotinamide riboside and pterostilbene reduces frequency and severity of undesirable symptoms of the menopause transition: an open-label, pilot clinical trial. Frontiers in Aging. https://www.frontiersin.org/journals/aging/articles/10.3389/fragi.2026.1773667/full
  15. Tru Niagen (2026). Tru Niagen 300 mg product and pricing. Tru Niagen website.
  16. Tru Niagen (2026). Refund policy. Tru Niagen website.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.